CSHL Stories and Media archive for Tag: RNA splicing

Cutting off liver cancer’s nutrient supply chain

2/3/2022

CSHL researchers developed a way to interfere with the energy pathway that allows liver cancer to grow and spread. Read the story »

Editing RNA to fix protein problems in cystic fibrosis

1/27/2022

CSHL researchers found a new way to address a previously untreatable class of mutations in the cystic fibrosis gene. Read the story »

The rise of RNA therapeutics

10/14/2021

RNA has been making waves as a new approach to prevent or treat diseases, including COVID-19 and spinal muscular atrophy. Read the story »

Krainer wins Pew grant to study fetal alcohol syndrome

9/15/2021

CSHL Professor Adrian Krainer will study RNA splicing errors that occur in people with the disease and look for treatment targets. Read the story »

Adenovirus: After 40 years, a call to arms

5/21/2021

Virus research done 40 years ago at CSHL provided an early foundation for today’s adenovirus-based treatments and vaccines. Read the story »

Krainer wins 2021 Wolf Prize in Medicine

2/17/2021

CSHL Professor Adrian Krainer was awarded the 2021 Wolf Prize in Medicine for his work on RNA splicing. Read the story »

Krainer wins 2020 NYAS Innovators prize for SMA research

7/8/2020

Professor Adrian Krainer is the 2020 Senior Scientist Winner of the Innovators in Science Award for his work on SPINRAZA^®. Read the story »

Adrian Krainer elected to the National Academy of Sciences

4/28/2020

Professor Adrian Krainer was elected to the National Academy of Science as part of its 2020 election. Read the story »

Humans of Banbury: Interview with Stephen Kaler

4/15/2020

An interview with March’s "Copper Cancer Consortium" meeting participant Stephen Kaler, M.D., M.P.H. Read the story »

Adrian Krainer wins Ross Prize in Molecular Medicine

3/2/2020

Professor Adrian Krainer wins the Ross Prize for his pioneering work on antisense therapy and its application to treating SMA. Read the story »

Mutation’s role in blood cancers revealed by ideal team-up

1/31/2020

Researchers from CSHL and MSKCC have determined how a mutation implicated in many blood cancers reduces the proteins that make healthy blood cells. Read the story »

Mutation’s role in blood cancers revealed by ideal collaboration

1/31/2020

Researchers from CSHL and MSKCC have determined how a mutation implicated in many blood cancers reduces the proteins that make healthy blood cells. Watch the video »

Nobel Prize day quiz

How much do you know about the Nobel Prize-winning science that happened at CSHL? Take our quiz to find out. Take the quiz »

Researchers identify gene behind spread of deadly breast cancer

12/9/2019

Jackson Laboratory and Cold Spring Harbor Laboratory researchers uncovered novel targets for therapies related to deadly triple negative breast cancers. Read the story »

Adrian Krainer wins 2019 Peter Speiser Award

11/27/2019

Professor Adrian Krainer was awarded the Peter Speiser Award for advances in the pharmaceutical sciences. Read the story »